Trade Dispute
German pharmaceutical industry benefits from US tariff dispute
The German pharmaceutical industry sees 3.2 percent production growth amid overall economic decline. This stems from the US tariff dispute, prompting rushed exports. The Association of Research-Based Pharmaceutical Companies (VFA) anticipates sustained high turnover through year-end.